Neurode

Neurode

Private
Sydney, New South WalesHealthcare & Life Scienceshttps://www.neurodelabs.com

Last Round

Pre Seed

Sep 10, 2024

Total Funding Raised

$3.5M

Momentum Score

50 /100

Company Overview

Neurode is a healthcare technology company that develops a wearable headset offering a drug-free treatment for ADHD through non-invasive electrical stimulation to enhance cognitive performance and alleviate symptoms such as working memory, attention, and impulse control.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Health IoT, Clinical Trials, Medical AI

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

ADHD treatmentneuromodulationdrug-free treatmentwearable headbandnon-invasive brain stimulationneurotechtranscranial Random Noise StimulationtRNSdigital therapeuticDTxbrain monitoringADHD wearablefunctional near-infrared spectroscopyfNIRSmedical devicehardware subscriptiondirect-to-consumerAI assistant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurode Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurode Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 10, 2024

Neurode Investors

Notable investors and investment history

InvestorRounds
Khosla VenturesPre Seed
Stoic Venture CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 87% MoM, reaching 14.8K.

  • May 18, 2026

    Open roles increased to 8, representing 53% of headcount.

Neurode Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurode Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurode's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney, New South Wales
Employee Range15
Year Founded2021
Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.